These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides. Youssefyeh RD; Campbell HF; Klein S; Airey JE; Darkes P; Powers M; Schnapper M; Neuenschwander K; Fitzpatrick LR; Pendley CE J Med Chem; 1992 Mar; 35(5):895-903. PubMed ID: 1312602 [TBL] [Abstract][Full Text] [Related]
11. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues. Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360 [TBL] [Abstract][Full Text] [Related]
12. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat. Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255 [TBL] [Abstract][Full Text] [Related]
13. Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease. Barnes NM; Costall B; Naylor RJ; Williams TJ; Wischik CM Neuroreport; 1990; 1(3-4):253-4. PubMed ID: 1966609 [TBL] [Abstract][Full Text] [Related]
14. Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride. Barnes NM; Costall B; Ironside JW; Naylor RJ J Pharm Pharmacol; 1988 Sep; 40(9):668. PubMed ID: 2907045 [No Abstract] [Full Text] [Related]
15. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues. Ge J; Barnes JM; Towers P; Barnes NM Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265 [TBL] [Abstract][Full Text] [Related]
16. Autoradiographic localization of the [3H]-(S)-zacopride labelled 5-HT3 receptor in porcine brain. Fletcher S; Barnes NM Neurosci Lett; 1999 Jul; 269(2):91-4. PubMed ID: 10430512 [TBL] [Abstract][Full Text] [Related]
17. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret. King GL J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943 [TBL] [Abstract][Full Text] [Related]
18. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret. Middlefell VC; Price TL Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684 [TBL] [Abstract][Full Text] [Related]
19. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog. Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791 [TBL] [Abstract][Full Text] [Related]
20. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons. Wade PR; Mawe GM; Branchek TA; Gershon MD Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]